04/11/2024
12:22 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
5:55 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
5:22 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
7:45 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
6:54 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/25/2024
6:28 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
4:27 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
03/19/2024
3:31 PM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form F-3ASR | |
03/19/2024
5:02 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
6:29 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:30 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:34 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:06 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
6:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form CERT | |
03/05/2024
3:40 PM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 8-A12B | |
03/04/2024
5:33 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024
9:39 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024
5:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
5:08 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
7:32 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/21/2024
7:13 AM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/21/2024
5:04 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
8:25 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:51 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/20/2024
6:49 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:52 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:47 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:27 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
9:13 AM | ADC Therapeutics SA (Subject)
ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
| Form SC 13G/A | |
02/08/2024
5:40 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024
9:30 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2024
4:23 PM | ASTRAZENECA PLC (Subject)
AstraZeneca (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/19/2024
7:46 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/19/2024
7:31 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
01/10/2024
7:39 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/02/2024
9:53 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
7:03 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T | |
12/27/2023
6:09 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2023
4:25 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023
5:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
9:20 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-C | |
12/12/2023
5:26 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:50 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:53 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
5:26 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2023
6:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/17/2023
5:36 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
10:16 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Cellectis S.A. (Subject)
| Form SC 13D/A | |
11/14/2023
5:39 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:19 AM | ASTRAZENECA PLC (Subject)
AstraZeneca (Subject)
SARIN ARADHANA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
9:01 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
9:05 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
8:49 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
8:57 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
11:24 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
5:38 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
6:36 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
6:36 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023
9:27 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
11:49 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023
5:55 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023
10:00 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023
10:07 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2023
5:59 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
9:20 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
11:23 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023
7:46 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023
5:25 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2023
1:08 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
12:35 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
7:30 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023
4:28 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/09/2023
5:38 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
5:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023
11:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
11:00 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
11:07 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
5:36 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
5:18 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/25/2023
3:39 PM | ASTRAZENECA PLC (Subject)
AstraZeneca (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/22/2023
5:53 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2023
5:43 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
05/09/2023
5:56 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
5:46 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
9:25 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
8:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
6:42 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/27/2023
11:31 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/27/2023
5:44 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2023
11:17 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
